Wilhelmus Cm Groenhuysen, Chief Financial Officer at NovoCure Ltd (NVCR), sold 25,972 shares at $81.66 ($2.1M) on 2019-11-14, disclosed to the SEC on 2019-11-15.
Open-market sale of $2.1M NVCR by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.78 | 2,000 | $162K | 7.6% |
| 2 | $81.66 | 2,805 | $229K | 10.8% |
| 3 | $81.67 | 10,800 | $882K | 41.5% |
| 4 | $81.80 | 1,403 | $115K | 5.4% |
| 5 | $82.50 | 1,764 | $146K | 6.8% |
| 6 | $82.54 | 7,200 |
| $594K |
| 27.9% |
| Total | $81.90 avg | 25,972 | $2.1M | 100% |
| Filing → |
| NVCR | SELL | 2023-09-05 | $6K | — | Filing → |
| NVCR | SELL | 2023-03-07 | $3.9M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $183K | — | Filing → |